Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy

(2015) Midori Ikeda et al.   Drug Metabolism and Pharmacokinetics

Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia

(2015) Hui He et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

(2015) J E Megías-Vericat et al.   PHARMACOGENOMICS JOURNAL

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

(2015) J E Megías-Vericat et al.   PHARMACOGENOMICS JOURNAL

Impact ofABCB1single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival inFLT3wild-typede novoAML patients with normal karyotype

(2014) Ingrid Jakobsen Falk et al.   BRITISH JOURNAL OF HAEMATOLOGY

ABCB1polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

(2014) Hee-Jun Kim et al.   CANCER SCIENCE

Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort

(2014) Eugenia Ulzurrun et al.   PLoS One

Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)

(2013) C. Vulsteke et al.   ANNALS OF ONCOLOGY

Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy

(2013) M. Tiribelli et al.   HAEMATOLOGICA

Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia

(2013) Sook Wah Yee et al.   JOURNAL OF HUMAN GENETICS

Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy

(2012) Kyu-pyo Kim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients

(2012) Marcos Antonio Mauricio Scheiner et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia

(2011) N. Colovic et al.   BIOMEDICINE & PHARMACOTHERAPY

Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia

(2011) Fang Wang et al.   EUROPEAN JOURNAL OF CANCER

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

(2011) Henk Visscher et al.   JOURNAL OF CLINICAL ONCOLOGY

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

(2010) D. Grimwade et al.   BLOOD

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

(2010) H Gréen et al.   PHARMACOGENOMICS JOURNAL

mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death

(2009) Maria A.A. Cortez et al.   PEDIATRIC BLOOD & CANCER

Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients

(2008) Suman Lal et al.   CANCER SCIENCE

C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia

(2008) Eun-Hye Hur et al.   LEUKEMIA RESEARCH

Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups

(2008) Phillip Müller et al.   LEUKEMIA RESEARCH

Acute Myeloid Leukemia: The Challenge of Capturing Disease Variety

(2008) B. Lowenberg   Hematology-American Society of Hematology Education Program